J A W Hagemans
Overview
Explore the profile of J A W Hagemans including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
84
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Rees J, Hoppener D, Hagemans J, Rothbarth J, Grunhagen D, Nuyttens J, et al.
Eur J Surg Oncol
. 2021 Jan;
47(7):1616-1622.
PMID: 33446352
Aim: To evaluate the clinical relevance of indeterminate lung nodules (ILN) in patients with locally recurrent rectal cancer (LRRC) treated in a tertiary referral centre. Methods: All patients with LRRC...
2.
Hagemans J, Voogt E, Rothbarth J, Nieuwenhuijzen G, Kirkels W, Boormans J, et al.
Eur J Surg Oncol
. 2020 Mar;
46(6):1160-1166.
PMID: 32122756
Introduction: Surgery for locally advanced rectal cancer (LARC) or locally recurrent rectal cancer (LRRC) may require total pelvic exenteration with the need for urinary diversion. The aim of this study...
3.
Hagemans J, van Rees J, Alberda W, Rothbarth J, Nuyttens J, van Meerten E, et al.
Eur J Surg Oncol
. 2019 Nov;
46(3):448-454.
PMID: 31761506
Introduction: The majority of patients with locally recurrent rectal cancer (LRRC) present with extensive metastatic disease or an unresectable recurrence, and will be treated palliatively. Only a minority of patients...
4.
Blok R, Hagemans J, Burger J, Rothbarth J, van der Bilt J, Lapid O, et al.
Tech Coloproctol
. 2019 Aug;
23(8):751-759.
PMID: 31432332
Background: Abdominoperineal resection (APR) carries a high risk of perineal wound morbidity. Perineal wound closure using autologous tissue flaps has been shown to be advantageous, but there is no consensus...
5.
Hagemans J, Rothbarth J, van Bogerijen G, van Meerten E, Nuyttens J, Verhoef C, et al.
Ann Surg Oncol
. 2019 Feb;
26(4):1134-1141.
PMID: 30725310
Background: Inguinal lymph node metastases (ILNM) from rectal adenocarcinoma are rare and staged as systemic disease. This study aimed to provide insight into the treatment and prognosis of ILNM from...
6.
Hagemans J, Alberda W, Verstegen M, de Wilt J, Verhoef C, Elferink M, et al.
Eur J Surg Oncol
. 2019 Jan;
45(4):613-619.
PMID: 30600101
Background: Clinically staged T1-3 rectal cancer (cT1-3) is generally treated by total mesorectal excision(TME) with or without neoadjuvant therapy and sometimes requires beyond TME-surgery, whereas cT4 rectal cancer often requires...
7.
8.
Hagemans J, Rothbarth J, Kirkels W, Boormans J, van Meerten E, Nuyttens J, et al.
Eur J Surg Oncol
. 2018 Aug;
44(10):1548-1554.
PMID: 30075979
Background: Total pelvic exenteration (TPE) is a radical approach for locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) in case of tumour invasion into the urogenitary tract....
9.
Hagemans J, Blinde S, Nuyttens J, Morshuis W, Mureau M, Rothbarth J, et al.
Ann Surg Oncol
. 2018 Apr;
25(7):1970-1979.
PMID: 29691737
Background: Failure of chemoradiotherapy (CRT) for anal squamous cell carcinoma (SCC) results in persistent or recurrent anal SCC. Treatment with salvage abdominoperineal resection (APR) can potentially achieve cure. The aims...
10.
Jonker F, Hagemans J, Verhoef C, Burger J
Eur J Surg Oncol
. 2017 Aug;
43(10):1894-1900.
PMID: 28822603
Background: The purpose of this study was to investigate the impact of hospital volume on perioperative outcomes of clinical tumour stage (cT)1-3 and cT4 rectal cancer. Methods: 16.162 patients operated...